From: Management of status epilepticus in pregnancy: a clinician survey
Managed status epilepticus in a pregnant patient (n = 100) | |
Yes | 67 |
No | 33 |
Number of pregnant patient with SE managed in the past year (n = 98) | |
0 | 50 |
1 | 27 |
2–5 | 20 |
> 5 | 1 |
Etiology of status epilepticus in pregnancy that respondents have Managed* | |
Eclampsia | 41 |
Prior diagnosis of epilepsy | 50 |
Vascular lesion | 29 |
Tumor/mass lesion | 12 |
Meningitis/encephalitis | 10 |
Autoimmune/paraneoplastic | 8 |
Traumatic brain injury | 8 |
Toxic/metabolic | 11 |
Other | 3 |
Unknown | 4 |
Never managed | 27 |
Is your general approach for SE treatment different in pregnant patients (n = 100) | |
Yes | 73 |
No | 27 |
Epilepsy consult for management of SE in pregnant patient (n = 99) | |
Always | 35 |
Usually | 6 |
Sometimes | 17 |
Never | 8 |
Would like to, but no epileptologist available | 4 |
Not applicable/I am an epileptologist | 29 |
Obstetrics/maternal fetal medicine consult (n = 98) | |
Always | 80 |
Usually | 6 |
Sometimes | 3 |
Never | 1 |
3rd trimester only | 2 |
Not applicable | 6 |
Anti-seizure medications avoided in treatment of SE in pregnancy* | |
Levetiracetam | 1 |
Fos-phenytoin/phenytoin | 42 |
Valproate | 85 |
Lacosamide | 3 |
Phenobarbital | 51 |
Other | 2 |
Does gestational age factor into your treatment decision (n = 100) | |
Yes | 79 |
No | 21 |